CDx Diagnostics Showcases WATS3D Test Advances at DDW 2025 Conference At the upcoming DDW 2025, CDx Diagnostics will unveil new clinical data supporting the WATS3D test's role in Barrett's esophagus detection.

CDx Diagnostics Showcases WATS3D Test Advances at DDW 2025 Conference #United_States #San_Diego #WATS3D #CDx_Diagnostics #Barrett's_Esophagus

Major Expansion in Esophageal Cancer Detection Coverage Reaches 73 Million Lives CDx Diagnostics announces a significant expansion of its WATS3D solution's insurance coverage, bringing it to 73 million lives, enhancing early esophageal cancer detection.

Major Expansion in Esophageal Cancer Detection Coverage Reaches 73 Million Lives #United_States #WATS3D #Esophageal_Cancer #CDx_Diagnostics #Suffern

WATS3D Assay: A Breakthrough in Early Esophageal Disease Detection The WATS3D assay is revolutionizing the early detection of esophageal diseases, particularly in high-risk areas like Arkansas.

WATS3D Assay: A Breakthrough in Early Esophageal Disease Detection #United_States #WATS3D #Dan_Lister #Arkansas_Heartburn #Suffern,_NY